November 3, 2009 – Abbott yesterday said both the XIENCE PRIME Everolimus-Eluting Coronary Stent System and the XIENCE V Everolimus-Eluting Coronary Stent System have received additional new CE markings covering the treatment of patients with diabetes.
November 3, 2009 – By relying solely on a patient’s clinical risk profile or the results of one imaging test when assessing patients with chest pain, physicians may be missing important, early signs of atherosclerotic disease and opportunities to intervene, according to new findings published in the Nov. 10, 2009 issue of the Journal of the American College of Cardiology (JACC).
November 3, 2009 – The FDA said Boston Scientific recently changed the name of the company's Liberté Bare-Metal coronary stent to VeriFLEX, after reports that Liberté Bare-Metal stents were inadvertently implanted instead of TAXUS Liberté Drug-Eluting stents, and vice versa. ??
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 2, 2009 – Toshiba America Medical Systems, Inc. has introduced the Aplio MX ultrasound system, a compact system that offers premium clinical performance and high-end features at an affordable price point.
November 2, 2009 — Clinical trial results published in this week’s Journal of the American College of Cardiology (JACC) describe six-month outcomes for patients using the Melody Transcatheter Pulmonary Valve from Medtronic, Inc.
November 2, 2009 — Cardiac complications around the time of noncardiac surgery are relatively common and can be serious.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 2, 2009 — St. Rose Hospital of Hayward, Calif., is accelerating report turnaround times and providing cardiologists with secure remote access to echocardiogram and EKG reports, thanks to a new cardiovascular information solution (CVIS) from McKesson.
November 2, 2009 — Ascent Healthcare Solutions said last week it received the industry’s first and only 510(k) clearance from the U.S. Food and Drug Administration to reprocess the Biosense Webster SoundStar 3D Diagnostic Ultrasound Catheter.
November 2, 2009 — Increasing the flexibility and diagnostic capabilities in bi-plane vascular X-ray imaging, Toshiba America Medical Systems Inc. introduces the all new Infinix VF-i/BP with large and mid-sized flat panel detectors.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 29, 2009 – The American College of Cardiology today launched the PINNACLE Network, the first-ever registry-based cardiovascular network to link thousands of cardiology practices to one another and to the ACC’s National Cardiovascular Data Registry (NCDR), the pre-eminent cardiovascular data repository in the United States.
October 29. 2009 – Results of the SLIM Study ("Slo-Niacin and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia") were recently published in the Journal of Clinical Lipidology.
October 28, 2009 – Thermo Fisher Scientific Inc. today announced the availability in Europe of its new Copeptin assay, which helps medical personnel quickly and accurately diagnose acute myocardial infarction (AMI).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 27, 2009 - Ziosoft Inc., an advanced visualization and analysis software for medical imaging company, and iMedIT, one of Turkey’s leading suppliers of PACS and teleradiology systems, today announced that they have signed an agreement for iMedIT to sell Ziosoft’s 3D advanced visualization software in Turkey.
October 28, 2009 - The imaging industry, especially the new molecular technologies, will drive personalized medicine, in which therapy is designed for the individual patient, according to a report by the market research group Kalorama Information.
October 27, 2009 – Interim six-month clinical results on the use of the FlexStent Femoropopliteal Self Expanding Stent System in the Superficial Femoral Artery were presented today at the VIVA conference by William Gray, M.D., of New York Columbia-Presbyterian Hospital.